163 related articles for article (PubMed ID: 23338488)
1. Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression.
Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Murawaki Y; Kakite S; Yamashita E
J Gastroenterol; 2013 Nov; 48(11):1283-92. PubMed ID: 23338488
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma.
Koda M; Tokunaga S; Okamoto T; Hodozuka M; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Sugihara T; Oyama K; Hosho K; Okano J; Murawaki Y; Kakite S; Yamashita E
J Hepatol; 2015 Dec; 63(6):1360-7. PubMed ID: 26232269
[TBL] [Abstract][Full Text] [Related]
3. Assessment of ablative margin by MRI with ferucarbotran in radiofrequency ablation for liver cancer: comparison with enhanced CT.
Tokunaga S; Koda M; Matono T; Sugihara T; Nagahara T; Ueki M; Murawaki Y; Kakite S; Yamashita E
Br J Radiol; 2012 Jun; 85(1014):745-52. PubMed ID: 21385915
[TBL] [Abstract][Full Text] [Related]
4. Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition.
Koda M; Tokunaga S; Fujise Y; Kato J; Matono T; Sugihara T; Nagahara T; Ueki M; Murawaki Y; Kakite S; Yamashita E
Eur J Radiol; 2012 Jul; 81(7):1400-4. PubMed ID: 21440397
[TBL] [Abstract][Full Text] [Related]
5. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging.
Kim SM; Shin SS; Lee BC; Kim JW; Heo SH; Lim HS; Jeong YY
Abdom Radiol (NY); 2017 Oct; 42(10):2527-2537. PubMed ID: 28409202
[TBL] [Abstract][Full Text] [Related]
6. Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide.
Fukuda K; Mori K; Hasegawa N; Nasu K; Ishige K; Okamoto Y; Shiigai M; Abei M; Minami M; Hyodo I
Jpn J Radiol; 2019 Jul; 37(7):555-563. PubMed ID: 31102138
[TBL] [Abstract][Full Text] [Related]
7. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
[TBL] [Abstract][Full Text] [Related]
8. Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma.
Wang XL; Li K; Su ZZ; Huang ZP; Wang P; Zheng RQ
World J Gastroenterol; 2015 May; 21(17):5345-51. PubMed ID: 25954109
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
10. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
11. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
12. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.
Hao Y; Numata K; Ishii T; Fukuda H; Maeda S; Nakano M; Tanaka K
World J Gastroenterol; 2017 May; 23(17):3111-3121. PubMed ID: 28533668
[TBL] [Abstract][Full Text] [Related]
13. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic distant recurrence following complete radiofrequency ablation of small hepatocellular carcinoma: risk factors and early MRI evaluation.
Sheng RF; Zeng MS; Ren ZG; Ye SL; Zhang L; Chen CZ
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):603-12. PubMed ID: 26663008
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation.
Nishikawa H; Inuzuka T; Takeda H; Nakajima J; Sakamoto A; Henmi S; Matsuda F; Eso Y; Ishikawa T; Saito S; Kita R; Kimura T; Osaki Y
J Gastroenterol; 2011 Dec; 46(12):1418-26. PubMed ID: 21845378
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justified?
Ke S; Ding XM; Qian XJ; Zhou YM; Cao BX; Gao K; Sun WB
World J Gastroenterol; 2013 Nov; 19(42):7389-98. PubMed ID: 24259969
[TBL] [Abstract][Full Text] [Related]
17. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran--feasibility study.
Mori K; Fukuda K; Asaoka H; Ueda T; Kunimatsu A; Okamoto Y; Nasu K; Fukunaga K; Morishita Y; Minami M
Radiology; 2009 May; 251(2):557-65. PubMed ID: 19251941
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.
Nakazawa T; Kokubu S; Shibuya A; Ono K; Watanabe M; Hidaka H; Tsuchihashi T; Saigenji K
AJR Am J Roentgenol; 2007 Feb; 188(2):480-8. PubMed ID: 17242258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
